SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 77.61+3.5%Nov 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1906)1/26/2008 12:45:34 AM
From: Jibacoa  Read Replies (1) of 3722
 
ALSE, the former Boston Life Sciences, was up 11.7% on very small volume of only 600 shrs., about 0.001 of its ADV.

The stock is getting close to its resistance at the $3 level

bigcharts.marketwatch.com

ALSE is trying to develop drugs to treat injuries and degenerative diseases & has intellectual property in the field of regenerative therapeutics.

Its Cethrin, is a recombinant-protein-based drug designed to stimulate nerve repair after acute spinal cord injury. In its PIa, it showed some positive results.On Jan 7, it announced that it has concluded enrollment in the PI/IIa for acute spinal cord injury.

ALSE also has in its pipeline Inosine for the treatment of spinal cord injury & stroke; Oncomodulin for the treatment of ocular injury & disease, & some research programs for a number of regenerative therapies including bone repair.

It also has a molecular imaging program targeting diagnosis of Parkinson's & ADHD. Its molecular imaging product candidate is ALTROPANE, which is in PIII for diagnosis of Parkinson's Disease. It has research collaborations with Harvard & Boston's Children's Hospital.

The stock needs to close above $3 in order to get off from the DT coming from its June H at 3.52

bigcharts.marketwatch.com.

And then it would have to deal with the Aug-Sep 2006 double top at the 4.24 level

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext